Enter your login e-mail to the account
Search
- Sacituzumab govitekan – drug profile
MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Drugs & drug classes ) - Publikujeme v zahraničí
(6/2014, Information & comments ) - Current options in the treatment of HER2 low metastatic breast cancer
MUDr. Radovan Barila, PhD.
(2/2024, Review articles ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - ECCO15 – ESMO34, Berlín 20. – 24. 9. 2009
MUDr. Juraj Beniak
(6/2009, Information & comments ) - Therapeutic procedures in the treatment of advanced triple-negative breast cancer – a nationwide survey among selected oncologists from oncology institutes and regional cancer centers in Slovakia
MUDr. Radovan Barila, PhD., MUDr. Elena Marušáková, MBA, Ing. Jan Žigmond
(3/2024, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Aktuálne z ASCO 2009
doc. MUDr. Peter Beržinec, CSc., prof. MUDr. Stanislav Špánik, CSc., MUDr. Marián Streško
(4/2009, Events ) - Advances in the treatment of triple- negative breast cancer
MUDr. Lea Balážová, doc. MUDr. Igor Andrašina, CSc.
(5/2022, Review articles ) - Správa z Best of ASCO® Slovakia 2011
MUDr. Mária Rečková
(1/2012, Events ) - Publikujeme v zahraničí
(5/2015, Information & comments ) - Neoadjuvant therapy of triple-negative breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(4/2020, Review articles ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes )
- Proteomic analysis of CD14 peripheral blood monocytes in patients with triple negative breast cancer
MUDr. Róbert Kilík, PhD., RNDr. Peter Bober, PhD., RNDr. Martin Menkyna, PhD., MUDr. Marek Lenárt, prof. MUDr. Jozef Radoňak, CSc., MPH
(4e/2023, Original articles )